共 121 条
[21]
Ang L(2011)Platelets as potent signaling entities in type 2 diabetes mellitus Life Sci. 88 839-2557
[22]
Behnamfar O(2019)Fibrinogen as a key regulator of inflammation in disease Trends Endocrinol Metab 30 532-550
[23]
Palakodeti S(2012)Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study Semin Immunopathol. 34 43-1131
[24]
Kaptoge S(2006)Elevated serum fibrinogen is associated with 12-month major adverse cardiovascular events following percutaneous coronary intervention Eur Heart J 27 2962-2505
[25]
Di Angelantonio E(2016)Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study J Am Coll Cardiol 67 2556-1003
[26]
Pennells L(2013)Antiinflammatory therapy with canakinumab for atherosclerotic disease Eur J Epidemiol 28 541-413
[27]
Danaei G(2017)Efficacy and safety of low-dose colchicine after myocardial infarction N Engl J Med 377 1119-1158
[28]
Finucane MM(2019)Platelet activity and hypercoagulation in type 2 diabetes N Engl J Med 381 2497-9
[29]
Lu Y(2018)Are insulin resistance and atherosclerosis the consequences of oxidative stress? Cardiovasc Diabetol. 17 141-3217
[30]
Wang L(1996)Inflammation markers and metabolic characteristics of subjects with 1-h plasma glucose levels Diabetologia 39 1002-1318